Expression of functional angiotensin-converting enzyme and AT1 receptors in cultured human cardiac fibroblasts.

BACKGROUND Angiotensin II (Ang II) has been implicated in the development of cardiac fibrosis. The aims of the present study were to examine expression and activity of ACE and of angiotensin receptors in human cardiac fibroblasts cultured from dilated cardiomyopathic and ischemic hearts. The effects of Ang II on fibroblasts were also investigated. METHODS AND RESULTS Human cardiac fibroblasts were cultured from ventricular and atrial myocardium and characterized immunohistochemically. Expression of ACE and the angiotensin AT1 receptor was demonstrated in cardiac fibroblasts by reverse transcriptase-polymerase chain reaction and radioligand binding. Functional ACE activity, measured by radiolabeled substrate conversion assay, was detected in both ventricular (Vmax. Km-1. mg-1, 0.031+/-0.010; n=13) and atrial (0. 034+/-0.012; n=6) fibroblasts. Fibroblast ACE activity was increased after 48 hours of treatment with basic fibroblast growth factor, dexamethasone, and phorbol ester. Ang II did not affect DNA synthesis but stimulated [3H]proline incorporation in cardiac fibroblasts (20.0+/-4.0% increase above control by 10 micromol/L; P<0.05, n=7), which was abolished by losartan 10 micromol/L but not PD123319 1 micromol/L. Ang II also stimulated a rise in intracellular calcium (basal, 56+/-1 nmol/L; Ang II, 355+/-24 nmol/L) via the AT1 receptor, as shown by complete inhibition with losartan. CONCLUSIONS We have demonstrated expression and activity of ACE and AT1 receptor in cultured human cardiac fibroblasts. In addition, cardiac fibroblasts respond to Ang II with AT1 receptor-mediated collagen synthesis. The presence of local ACE and AT1 receptors in human fibroblasts suggests their involvement in the development of cardiac fibrosis.

[1]  J. Arends,et al.  AT2 receptor blockade reduces cardiac interstitial cell DNA synthesis and cardiac function after rat myocardial infarction. , 1998, Journal of molecular and cellular cardiology.

[2]  J. Ménard,et al.  Local angiotensin II generation in the rat heart: role of renin uptake. , 1998, Circulation research.

[3]  M. Yacoub,et al.  Growth response of human coronary smooth muscle cells to angiotensin II and influence of angiotensin AT1 receptor blockade , 1998, Coronary artery disease.

[4]  R. A. Rutherford,et al.  Differential distribution of angiotensin AT2 receptors in the normal and failing human heart. , 1998, The Journal of pharmacology and experimental therapeutics.

[5]  K. Weber,et al.  Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation. , 1997, Circulation.

[6]  Y. Mori,et al.  Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism. , 1997, Circulation.

[7]  K. Weber,et al.  Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion. , 1997, Cardiovascular research.

[8]  K. Weber,et al.  Cultured myofibroblasts generate angiotensin peptides de novo. , 1997, Journal of molecular and cellular cardiology.

[9]  N. Iwai,et al.  Assessment of the angiotensin II-forming pathway in human atria. , 1997, Heart and vessels.

[10]  M. Boddi,et al.  Evidence for the existence of a functional cardiac renin-angiotensin system in humans. , 1996, Circulation.

[11]  E. Miyamoto,et al.  Expression of angiotensin-converting enzyme in remaining viable myocytes of human ventricles after myocardial infarction. , 1996, Circulation.

[12]  M. L. Rose,et al.  Alloproliferation of purified CD4+ T cells to adult human heart endothelial cells, and study of second‐signal requirements , 1996, Immunology.

[13]  R. Virmani,et al.  Monocyte- and cytokine-induced downregulation of angiotensin-converting enzyme in cultured human and porcine endothelial cells. , 1996, Circulation research.

[14]  P. Erne,et al.  Angiotensin II-receptor subtypes in human atria and evidence for alterations in patients with cardiac dysfunction. , 1996, European heart journal.

[15]  A. Saalbach,et al.  Novel fibroblast-specific monoclonal antibodies: properties and specificities. , 1996, The Journal of investigative dermatology.

[16]  Y. Mori,et al.  Regulation of angiotensin II type 2 receptor gene by the protein kinase C-calcium pathway. , 1996, Hypertension.

[17]  K. Weber,et al.  Role of angiotensin II and prostaglandin E2 in regulating cardiac fibroblast collagen turnover. , 1995, The American journal of cardiology.

[18]  B. Groves,et al.  Angiotensin II formation in the intact human heart. Predominance of the angiotensin-converting enzyme pathway. , 1995, The Journal of clinical investigation.

[19]  E. Miyamoto,et al.  Increased angiotensin converting enzyme activity in left ventricular aneurysm of patients after myocardial infarction. , 1995, Cardiovascular research.

[20]  E. Fleck,et al.  Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts. , 1995, Circulation.

[21]  B. Berk,et al.  Glucocorticoids induce angiotensin-converting enzyme expression in vascular smooth muscle. , 1995, Hypertension.

[22]  R. Bohle,et al.  Cellular distribution of angiotensin-converting enzyme after myocardial infarction. , 1995, Hypertension.

[23]  M. Paul,et al.  The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. , 1995, The Journal of clinical investigation.

[24]  E. Nabel,et al.  Fibroblast growth factor stimulates angiotensin converting enzyme expression in vascular smooth muscle cells. Possible mediator of the response to vascular injury. , 1995, The Journal of clinical investigation.

[25]  K. Weber,et al.  Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat. , 1994, Cardiovascular research.

[26]  S. Yamada,et al.  Angiotensin II receptor subtypes in bovine and human ventricular myocardium. , 1994, The Journal of pharmacology and experimental therapeutics.

[27]  K. Weber,et al.  Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. , 1994, Journal of molecular and cellular cardiology.

[28]  J. Cleland,et al.  Co‐expression of renin—angiotensin system component genes in human atrial tissue , 1994, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[29]  P. Erne,et al.  Characterization of angiotensin II receptors in cultured adult rat cardiac fibroblasts. Coupling to signaling systems and gene expression. , 1994, The Journal of clinical investigation.

[30]  Noel N Kim,et al.  Identification of Functional Angiotensin II Receptors on Rat Cardiac Fibroblasts , 1993, Circulation.

[31]  P. Timmermans,et al.  Angiotensin II receptors and angiotensin II receptor antagonists. , 1993, Pharmacological reviews.

[32]  M. Paul,et al.  Gene expression of the renin-angiotensin system in human tissues. Quantitative analysis by the polymerase chain reaction. , 1993, The Journal of clinical investigation.

[33]  M. Schambelan,et al.  Characterization of angiotensin II receptor subtypes in rat heart. , 1992, Circulation research.

[34]  G. Aguilera,et al.  Angiotensin-II receptor subtypes and coupling to signaling systems in cultured fetal fibroblasts. , 1991, Endocrinology.

[35]  K. Weber,et al.  Pathological Hypertrophy and Cardiac Interstitium: Fibrosis and Renin‐Angiotensin‐Aldosterone System , 1991, Circulation.

[36]  M. Reidy,et al.  Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[37]  H. Schunkert,et al.  Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation. , 1990, The Journal of clinical investigation.

[38]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[39]  R. Tsien,et al.  A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.

[40]  I. Tikkanen,et al.  Inhibitor binding assay for angiotensin-converting enzyme. , 1984, Clinical chemistry.

[41]  C. Czeisler,et al.  Episodic 24-hour cortisol secretory patterns in patients awaiting elective cardiac surgery. , 1976, The Journal of clinical endocrinology and metabolism.